Hemodynamic and Biochemical Effects of the AT 1 Receptor Antagonist Irbesartan in Hypertension
- 1 January 1995
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 25 (1) , 22-29
- https://doi.org/10.1161/01.hyp.25.1.22
Abstract
We studied the hemodynamic, neurohumoral, and biochemical effects of the novel angiotensin type 1 (AT1) receptor antagonist irbesartan in 86 untreated patients with essential hypertension ...Keywords
This publication has 22 references indexed in Scilit:
- Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.Hypertension, 1993
- Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.Hypertension, 1993
- Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats.Hypertension, 1991
- Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753.Hypertension, 1990
- Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X.Hypertension, 1990
- Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension.Hypertension, 1990
- Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis.Hypertension, 1983
- Sodium intake and renal responses to captopril in normal man and in essential hypertensionKidney International, 1981
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978